Systematic review with meta‐analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies

0 / 5 (0 votos)
Systematic review with meta‐analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies

Alimentary Pharmacology & Therapeutics

Fecha de publicación: 19 december 2018

DOI: https://doi.org/10.1111/apt.15090

Autores: Christopher Ma, Leonardo Guizzetti, Lauren E. Cipriano, Claire E. Parker, Tran M. Nguyen, James C. Gregor, Nilesh Chande, Brian G. Feagan, Vipul Jairath.

Background: Aminosalicylates are the most frequently prescribed treatment for ulcerative colitis (UC). In the absence of empirical evidence, clinicians are uncertain whether to continue aminosalicylates in patients with UC after escalating therapy.

Seguir leyendo

 

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.